86 related articles for article (PubMed ID: 1755847)
1. Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor.
Seiler SM; Goldenberg HJ; Michel IM; Hunt JT; Zavoico GB
Biochem Biophys Res Commun; 1991 Dec; 181(2):636-43. PubMed ID: 1755847
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the "tethered-ligand" receptor in thrombin inhibition of platelet adenylate cyclase.
Seiler SM; Michel IM; Fenton JW
Biochem Biophys Res Commun; 1992 Feb; 182(3):1296-302. PubMed ID: 1371679
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
Lau LF; Pumiglia K; Côté YP; Feinstein MB
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist.
Seiler SM; Peluso M; Michel IM; Goldenberg H; Fenton JW; Riexinger D; Natarajan S
Biochem Pharmacol; 1995 Feb; 49(4):519-28. PubMed ID: 7872957
[TBL] [Abstract][Full Text] [Related]
5. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS
Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706
[TBL] [Abstract][Full Text] [Related]
6. The cleaved peptide of the thrombin receptor is a strong platelet agonist.
Furman MI; Liu L; Benoit SE; Becker RC; Barnard MR; Michelson AD
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3082-7. PubMed ID: 9501219
[TBL] [Abstract][Full Text] [Related]
7. Agonist receptors and G proteins as mediators of platelet activation.
Brass LF; Hoxie JA; Kieber-Emmons T; Manning DR; Poncz M; Woolkalis M
Adv Exp Med Biol; 1993; 344():17-36. PubMed ID: 8209785
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the "tethered ligand" receptor in thrombin-induced endothelium-mediated relaxations.
Tesfamariam B; Allen GT; Normandin D; Antonaccio MJ
Am J Physiol; 1993 Nov; 265(5 Pt 2):H1744-9. PubMed ID: 8238588
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
Burke FM; Warnock M; Schmaier AH; Mosberg HI
Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
[TBL] [Abstract][Full Text] [Related]
10. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor.
Chao BH; Kalkunte S; Maraganore JM; Stone SR
Biochemistry; 1992 Jul; 31(27):6175-8. PubMed ID: 1320929
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of alpha-thrombin-induced platelet activation.
Hasan AA; Amenta S; Schmaier AH
Circulation; 1996 Aug; 94(3):517-28. PubMed ID: 8759097
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of the two forms of GPIb functioning as receptors for alpha-thrombin and von Willebrand factor: Ca2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide.
Greco NJ; Jones GD; Tandon NN; Kornhauser R; Jackson B; Jamieson GA
Biochemistry; 1996 Jan; 35(3):915-21. PubMed ID: 8547273
[TBL] [Abstract][Full Text] [Related]
13. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
14. Effects of thrombin receptor activating peptide on phosphoinositide hydrolysis and protein kinase C activation in cultured rat aortic smooth muscle cells: evidence for "tethered-ligand" activation of smooth muscle cell thrombin receptors.
Webb ML; Taylor DS; Molloy CJ
Biochem Pharmacol; 1993 Apr; 45(8):1577-82. PubMed ID: 8387299
[TBL] [Abstract][Full Text] [Related]
15. A peptide analogue of thrombin receptor-activating peptide inhibits thrombin and thrombin-receptor-activating peptide-induced vascular smooth muscle cell proliferation.
Pakala R; Liang CT; Benedict CR
J Cardiovasc Pharmacol; 2001 May; 37(5):619-29. PubMed ID: 11336112
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
[TBL] [Abstract][Full Text] [Related]
17. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
Hammes SR; Coughlin SR
Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
[TBL] [Abstract][Full Text] [Related]
18. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
McNicol A; Robson CA
J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
[TBL] [Abstract][Full Text] [Related]
19. A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacyclin production in human endothelial cells.
Ngaiza JR; Jaffe EA
Biochem Biophys Res Commun; 1991 Sep; 179(3):1656-61. PubMed ID: 1656962
[TBL] [Abstract][Full Text] [Related]
20. YD-3, a novel inhibitor of protease-induced platelet activation.
Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
